Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis

The monitoring of TB treatments in clinical practice and clinical trials relies on traditional sputum-based culture status indicators at specific time points. Accurate, predictive, blood-based protein markers would provide a simpler and more informative view of patient health and response to treatment.

Source: Tuberculosis - July 17, 2018 Category: Respiratory Medicine Authors: Komal Kedia, Jason Wendler, Erin S. Baker, Kristin E. Burnum-Johnson, Leah G. Jarsberg, Kelly G. Stratton, Aaron T. Wright, Paul D. Piehowski, Marina A. Gritsenko, David M. Lewinsohn, George B. Sigal, Marc H. Weiner, Richard D. Smith, Jon M. Jacobs, Payam Tags: Immunological Aspects Source Type: research